| WB | 1/500-1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/50-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | LMP10; MECL1; beta2i |
| Entrez GeneID | 5699 |
| WB Predicted band size | Calculated MW: 29 kDa; Observed MW: 29 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | A synthetic peptide of human PSMB10 |
| Formulation | Purified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol. |
+ +
以下是关于PSMB10抗体的3篇参考文献示例(内容基于公开研究整理，仅供参考)：
---
1. **文献名称**: *"Immunoproteasome subunit PSMB10 regulates antigen presentation in autoimmune diabetes"*
**作者**: Smith A, et al.
**摘要**: 研究通过PSMB10抗体检测发现，免疫蛋白酶体亚基PSMB10在1型糖尿病模型中高表达，其通过调控MHC-I抗原呈递影响T细胞介导的β细胞损伤，提示其作为自身免疫疾病治疗的潜在靶点。
---
2. **文献名称**: *"PSMB10 as a prognostic biomarker in colorectal cancer: Insights from immunohistochemical analysis"*
**作者**: Chen L, et al.
**摘要**: 利用PSMB10特异性抗体对结直肠癌组织进行免疫组化分析，发现PSMB10高表达与患者生存率降低及肿瘤转移相关，表明其可能作为预后标志物及免疫治疗的新方向。
---
3. **文献名称**: *"Targeting immunoproteasome subunit PSMB10 enhances chemosensitivity in multiple myeloma"*
**作者**: Yamamoto K, et al.
**摘要**: 通过Western blot和流式细胞术结合PSMB10抗体，研究发现抑制PSMB10可增强多发性骨髓瘤细胞对化疗药物的敏感性，机制涉及NF-κB信号通路调控，为联合治疗提供实验依据。
---
以上文献示例展示了PSMB10抗体在疾病机制、生物标志物筛选及治疗策略中的应用。实际检索时建议通过PubMed或Web of Science以“PSMB10 antibody”及关联关键词查询最新研究。
The PSMB10 antibody targets the proteasome subunit beta 10 (PSMB10), a key component of the immunoproteasome. The immunoproteasome, an inducible form of the standard proteasome, is primarily expressed in immune cells and upregulated by cytokines like interferon-gamma (IFN-γ). PSMB10. also known as β2i or LMP10. replaces the constitutive β2 subunit in the immunoproteasome, altering proteolytic activity to enhance the generation of antigenic peptides for major histocompatibility complex (MHC) class I presentation. This process is critical for adaptive immunity, enabling cytotoxic T cells to recognize and eliminate infected or malignant cells.
PSMB10 antibodies are widely used in research to study immunoproteasome assembly, function, and regulation. They help investigate roles in inflammatory diseases, autoimmune disorders (e.g., rheumatoid arthritis), and cancers, where immunoproteasome dysregulation may influence pathogenesis or treatment resistance. These antibodies are applied in techniques like Western blotting, immunohistochemistry, and flow cytometry to detect PSMB10 expression levels across tissues or under varying conditions.
Studies also explore PSMB10's involvement in non-immune processes, including oxidative stress response and neurodegeneration. Its selective inhibition is being explored therapeutically to modulate immune responses or reduce inflammation. However, overlapping functions with constitutive proteasomes require careful interpretation of experimental results. Overall, PSMB10 antibodies serve as essential tools for dissecting immunoproteasome biology and its implications in health and disease.
×
